홈 › 크론병 › 캘리포니아

캘리포니아의 크론병 임상 시험

크론병 관련 연구 35개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.

캘리포니아의 도시

공식 연구 텍스트(영어)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of California Davis Comprehensive Cancer Center, Sacramento

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03816345

A Study of SL-325 in Crohn's Disease Patients

Clinical Trial Site, Oxnard
Clinical Trial Site, Temple City
Clinical Trial Site, West Hills

피험자 모집 중2상

18세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07753850

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Clinnova Research ( Site 5110), Anaheim
Southern California Research Center ( Site 5044), Coronado
Om Research LLC ( Site 5038), Lancaster
외 5개

피험자 모집 중3상

16세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06430801

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Biopharma Informatic, LLC, Los Angeles
Om Research LLC, Oxnard

피험자 모집 중2상

18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07483073

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Smart Cures Clinical Research, Anaheim
Cedars-Sinai Medical Center, Beverly Hills
United Medical Doctors - Los Alamitos, Los Alamitos
외 1개

피험자 모집 중3상

18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Gastro Care Institute, Lancaster
Infinity Clinical Research, San Diego

피험자 모집 중2상

18세 ~ 85세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06226883

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Biopharma Informatic, LLC, Los Angeles
Om Research LLC, Oxnard

피험자 모집 중2상

18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07483099

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Southern California Research Center, Coronado
Om Research, LLC 1, Lancaster
외 6개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07196722

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Gastro SB Clinic, Chula Vista
United Medical Doctors, Los Alamitos
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07577843

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Cedars Sinai Medical Center, Los Angeles

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05923073

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Gastro Care Institute, Lancaster
United Gastroenterologists, Los Alamitos
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07499232

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

United Medical Doctors, Murrieta
UCI Health, Orange

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06233461

A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

Investigational Site Number: 8400005, Escondido
Investigational Site Number: 8400001, Lancaster
Investigational Site Number: 8400029, San Diego

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06958536

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Gastroenterology and Liver Institute, Escondido
United Clinical Research Institute, Murrieta

피험자 모집 중4상

18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06581328

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Clinnova Research /ID# 280509, Anaheim
Southern California Res. Ctr /ID# 280476, Coronado
Gastro Care Institute /ID# 281071, Lancaster
외 2개

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07697456

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Alliance Research Institute-Site Number: 8400008, Canoga Park
Southern California GI & Liver Centers-Site Number: 8400062, Coronado
Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
외 14개

피험자 모집 중3상

16세 ~ 80세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT05995353

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Loma Linda University, Loma Linda
Children's Hospital of Orange County, Orange

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06405087

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

UCSF Medical Center at Mission Bay, San Francisco

피험자 모집 중3상

2세 ~ 19세 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Cedars Sinai Medical Center, Los Angeles

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05509777

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Southern California Res. Ctr /ID# 265549, Coronado
UC San Diego Health System /ID# 265565, La Jolla
uc davis medical center - patient support services building /ID# 265554, Sacramento

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542